BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 69 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,423 | -19.3% | 10,300 | -8.0% | 0.03% | -15.4% |
| Q2 2023 | $183,904 | -32.3% | 11,200 | -31.1% | 0.04% | -36.1% |
| Q1 2023 | $271,538 | +4.9% | 16,250 | -3.1% | 0.06% | +3.4% |
| Q4 2022 | $258,838 | +3.5% | 16,775 | 0.0% | 0.06% | -13.2% |
| Q3 2022 | $250,000 | -9.4% | 16,775 | 0.0% | 0.07% | -2.9% |
| Q2 2022 | $276,000 | -29.0% | 16,775 | -13.4% | 0.07% | -13.6% |
| Q1 2022 | $389,000 | -22.2% | 19,375 | -1.7% | 0.08% | -20.6% |
| Q4 2021 | $500,000 | -16.4% | 19,705 | -11.1% | 0.10% | -23.3% |
| Q3 2021 | $598,000 | -8.3% | 22,155 | -1.8% | 0.13% | -14.7% |
| Q2 2021 | $652,000 | +22.1% | 22,555 | +11.1% | 0.16% | +4.7% |
| Q1 2021 | $534,000 | +145.0% | 20,296 | +167.1% | 0.15% | +122.4% |
| Q4 2020 | $218,000 | – | 7,600 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |